KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Accumulated Expenses (2020 - 2025)

Organon (OGN) has 6 years of Accumulated Expenses data on record, last reported at $1.3 billion in Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 5.39% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, down 5.39%, while the annual FY2025 figure was $1.3 billion, 5.39% down from the prior year.
  • Accumulated Expenses reached $1.3 billion in Q4 2025 per OGN's latest filing, down from $1.4 billion in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.5 billion in Q3 2024 and bottomed at $759.0 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2022.
  • Peak YoY movement for Accumulated Expenses: surged 54.93% in 2021, then fell 5.39% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $1.0 billion in 2021, then increased by 16.36% to $1.2 billion in 2022, then rose by 16.92% to $1.4 billion in 2023, then rose by 1.58% to $1.4 billion in 2024, then fell by 5.39% to $1.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $1.3 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.4 billion in Q2 2025.